About Smith & Nephew
Smith & Nephew is a global medical technology business, specializing in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were $3.4 billion.
About NUCRYST Pharmaceuticals
NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures
and commercializes medical products that fight infection and inflammation
using SILCRYST(TM), its patented atomically disordered nanocrystalline
silver technology. NUCRYST licensed world-wide rights for SILCRYST(TM)
wound care coating products to Smith & Nephew plc, which markets these
products in over 30 countries under their Acticoat(TM) trademark. NUCRYST
is also developing pharmaceutical products to address medical conditions
that are characterized by pain, infection and inflammation. The Company has
developed its proprietary nanocrystalline silver in a powder form, referred
to as N
'/>"/>
| SOURCE NUCRYST Pharmaceuticals Corp. Copyright©2008 PR Newswire. All rights reserved |